BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8426737)

  • 1. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells.
    Wang NP; To H; Lee WH; Lee EY
    Oncogene; 1993 Feb; 8(2):279-88. PubMed ID: 8426737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of cancer suppression by the retinoblastoma gene.
    Lee WH
    Princess Takamatsu Symp; 1989; 20():159-70. PubMed ID: 2488231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor and growth suppression of breast cancer cells by chromosome 17-associated functions.
    Negrini M; Sabbioni S; Haldar S; Possati L; Castagnoli A; Corallini A; Barbanti-Brodano G; Croce CM
    Cancer Res; 1994 Apr; 54(7):1818-24. PubMed ID: 8137297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.
    Li J; Hu SX; Perng GS; Zhou Y; Xu K; Zhang C; Seigne J; Benedict WF; Xu HJ
    Oncogene; 1996 Dec; 13(11):2379-86. PubMed ID: 8957079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G; Lo-Hsueh M; Lopez ME; Vogelstein B; Stanbridge EJ
    Oncogene; 1991 Oct; 6(10):1791-7. PubMed ID: 1923504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer.
    Navone NM; Rodriquez-Vargas MC; Benedict WF; Troncoso P; McDonnell TJ; Zhou JH; Luthra R; Logothetis CJ
    Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein.
    Vinyals A; Peinado MA; Gonzalez-Garrigues M; Monzó M; Bonfil RD; Fabra A
    Gene Ther; 1999 Jan; 6(1):22-33. PubMed ID: 10341872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of biological function of retinoblastoma gene (Rb gene).
    Chen D; Li D; Huang Q; Li A; Gu J; Luo C
    Zhonghua Yan Ke Za Zhi; 1995 Mar; 31(2):87-97. PubMed ID: 7656727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of wild-type p53 in human A673 cells suppresses tumorigenicity but not growth rate.
    Chen YM; Chen PL; Arnaiz N; Goodrich D; Lee WH
    Oncogene; 1991 Oct; 6(10):1799-805. PubMed ID: 1923505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of retinoblastoma tumor suppressor activity by RNA interference in lung cancer lines.
    Reed MF; Zagorski WA; Howington JA; Zilfou JT; Knudsen ES
    Ann Thorac Surg; 2006 Jul; 82(1):249-53. PubMed ID: 16798224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of distant pulmonary metastasis of MDA-MB 435 human breast carcinoma established in mammary fat pads of nude mice by retroviral-mediated TIMP-2 gene transfer.
    Lee YK; So IS; Lee SC; Lee JH; Lee CW; Kim WM; Park MK; Lee ST; Park DY; Shin DY; Park CU; Kim YS
    J Gene Med; 2005 Feb; 7(2):145-57. PubMed ID: 15546163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
    Wiman KG
    Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominance of wild-type p53-mediated transcriptional activation in breast epithelial cells.
    Davis P; Bazar K; Huper G; Lozano G; Marks J; Iglehart JD
    Oncogene; 1996 Sep; 13(6):1315-22. PubMed ID: 8808706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thirteen new p53 gene mutants identified among 41 human breast cancer cell lines.
    Wasielewski M; Elstrodt F; Klijn JG; Berns EM; Schutte M
    Breast Cancer Res Treat; 2006 Sep; 99(1):97-101. PubMed ID: 16541312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
    Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
    Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of the RB gene suppresses the growth of small-cell lung carcinoma cells carrying multiple genetic alterations.
    Ookawa K; Shiseki M; Takahashi R; Yoshida Y; Terada M; Yokota J
    Oncogene; 1993 Aug; 8(8):2175-81. PubMed ID: 8393162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of tumorigenicity of breast cancer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes.
    Theile M; Hartmann S; Scherthan H; Arnold W; Deppert W; Frege R; Glaab F; Haensch W; Scherneck S
    Oncogene; 1995 Feb; 10(3):439-47. PubMed ID: 7845668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells.
    Maeda T; Matsubara H; Koide Y; Sugaya M; Miyazawa Y; Tasaki K; Isono K; Ochiai T; Sakiyama S; Tagawa M
    Anticancer Res; 2000; 20(2A):869-74. PubMed ID: 10810368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line].
    Wang H; Lai B; Li J
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.